The Basse-Terre administrative court ordered the CHU and the Regional Health Agency (ARS) of Guadeloupe to order "sufficient numbers" of Covid-19 screening tests as well as treatment doses with hydroxychloroquine and azithromycin. Seized in summary procedure by the Guadeloupe union UGTG, the administrative court justifies its decision in particular by the weakness of the local health system, in its judgment rendered on Saturday.
The court mentioned "a particularly limited number of resuscitation beds in Guadeloupe", but also "the proven shortage of equipment to protect carers and law enforcement personnel and that of screening tests". These data are "constitutive of serious and manifestly illegal attacks on respect for life".
"Necessary doses"
The UGTG welcomed in a press release this judgment and assures the "people of Guadeloupe" to do everything possible to "compel the political and health authorities to respect (...) immediately the injunctions of the judge". But the union, which demanded 200,000 tests and what to treat 20,000 patients with companies already selected, was unsuccessful on this point.
In its injunction, the court gave no figures, speaking simply of "necessary doses" of treatment and "sufficient number" of tests. If the "CHU does not comment on a court decision" according to its direction, the ARS, it, "took note" of the judgment. She says she is "satisfied to see that the court did not ratify the request of the UGTG to buy tests and medicines in the quantities they requested without being experts and from the companies they cited", she wrote in a statement. She recalls that "the screening and treatment of the Guadeloupe population is done according to the rules laid down by law and ministerial recommendations".
Health
Coronavirus in overseas: the wave is not yet there, but local fragility worries
Society
Coronavirus: Flights between France and Overseas prohibited from Monday midnight
- Screening
- Justice
- Coronavirus
- Health
- Drug
- Guadeloupe